Clinical Trial Update: Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing immunogenicity and safety of polio booster dose across different primary sequential schedules in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: Zhejiang Provincial Center for Disease Control and Prevention | Conditions: Polio, Vaccine Reaction | Phase 4 | Status: COMPLETED